GlassScriptPhysician profile
Steve K Tseng
NPI 1316357841
$4,514.69
in general payments reported to CMS, 2019-2025
27 companies · $19.75 in 2025
The $19.75 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $335 · 2021: $900 · 2022: $1,095 · 2023: $658 · 2024: $93.27 · 2025: $19.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,078.28 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $691.00 | 2019-2023 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $570.03 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $292.51 | 2019-2022 | |
| Genentech USA, INC. | $266.54 | 2019-2021 | |
| Grifols USA, LLC | $174.27 | 2019 | |
| Pulmonx Corporation | $167.40 | 2021-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Genzyme Corporation | $151.27 | 2022-2023 | |
| United Therapeutics Corporation | $150.08 | 2019-2022 | |
| Mylan Specialty L.P. | $135.64 | 2019 | |
| Intuitive Surgical, INC. | $132.48 | 2023 | Da Vinci Surgical System |
| Philips North America LLC | $131.24 | 2019 | |
| Electromed, INC. | $121.77 | 2019-2024 | Smartvest |
| Janssen Pharmaceuticals, INC | $105.43 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $73.15 | 2019-2024 | Giapreza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $42.79 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $41.96 | 2022 | |
| Olympus America INC. | $27.66 | 2023 | Spin Vision Scope, 4.0mm Od, 2.0mm Wc |
| Harmony Biosciences LLC | $26.23 | 2022 | |
| Astellas Pharma US INC | $20.39 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $19.75 | 2025 | |
| Merck Sharp & Dohme LLC | $18.31 | 2022 | |
| Shire North American Group INC | $18.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.70 | 2022 | |
| Allergan, INC. | $16.67 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.